CTOs on the Move

Precision Advertising

www.precisioncg.com

 
Precision Advertising is a Pointe-Claire, QC-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.precisioncg.com
  • 6600 aut Transcanadienne
    Pointe-Claire, QC CAN H9R 4S2
  • Phone: 514.343.4949

Executives

Name Title Contact Details

Similar Companies

GeoMetrix Data Systems

GeoMetrix Data Systems Inc. is a Victoria, BC-based company in the Business Services sector.

10TH Degree

10TH Degree is a Lake Forest, CA-based company in the Business Services sector.

Beach-Russ Company

Beach-Russ Company is a Brooklyn, NY-based company in the Business Services sector.

Robertson and Robertson Yacht Insurance

Robertson and Robertson Yacht Insurance Ltd. is a North York, ON-based company in the Business Services sector.

Mural Oncology

We know that drug development is both an art and a science. The work we do is incredibly technical, intentional, and specific, but there is an art to it - because we must leave room for creativity, innovation and spontaneity. Murals are paintings that transform overlooked or unused spaces - creating something impactful and meaningful. There remains many overlooked opportunities in cancer drug development. This is what inspires us. Our mission is simple, to create novel immunotherapies that can change patients lives so they can get back to what matters most - living. Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Immunotherapies have been transformative for some people living with cancer, but unfortunately many patients still do not benefit - either because they are ineligible for treatment or they do not respond well to current therapies. We leverage our expertise in cytokine biology, immune cell modulation and our protein engineering capabilities to develop first and novel immunotherapies. Our goal is to deliver meaningful, clinical benefit across a wide range of cancers, including tumor types where immunotherapies have previously not been effective. Mural Oncology is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers. (NASDAQ: MURA)